Shares of NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) dropped 15.2% during trading on Friday . The company traded as low as $0.10 and last traded at $0.10. Approximately 23,248 shares changed hands during mid-day trading, an increase of 5% from the average daily volume of 22,074 shares. The stock had previously closed at $0.12.
NexImmune Trading Down 15.2 %
The company has a market capitalization of $139,639.50, a price-to-earnings ratio of -0.01 and a beta of 1.68. The business’s 50 day moving average price is $0.25 and its two-hundred day moving average price is $0.81.
NexImmune Company Profile
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Featured Articles
- Five stocks we like better than NexImmune
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- What Are Dividend Challengers?
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Investing in the High PE Growth Stocks
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
